The Cannabis Investing Podcast

Psychedelic stocks = super-risky biotechs low on cash. Make small bets.

Jul 16, 2023

49:22

Analyst Alex Carchidi returns to update investors on the psychedelics industry. This is the full conversation of an interview originally published on Investing Experts.

(2:50) Industry's collapse and consolidation
(5:00) Compass Pathways timeline for clinical trials
(15:00) Super-risky biotech companies low on cash - don't bet on just 1 company
(21:20) Atai and Cybin's recent wins
(32:55) Ketamine clinics and viable business models

Psychedelic Sunday: Scrutinizing Psychedelic Stocks
Cybin: A Leading Early-Stage Psychedelics Play
Psychedelic Sunday: Mushrooms Are The Key - Red Light Holland CEO Todd Shapiro
Numinus CEO Payton Nyquvest On Transforming Healthcare With Psychedelics

Podcast transcripts on Seeking Alpha

Cannabis Investing Podcast Twitter

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.